AQUINOX PHARMACEUTICALS, INC Business Finance Contracts & Agreements
30 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Facility Agreements (2)
- Loan Agreements (1)
- Purchase Agreements (4)
- Registration Rights Agreements (3)
- Security Agreements (2)
- Shareholders Agreements (4)
- Stock Agreements (3)
- Underwriting Agreements (5)
- Warrant Agreements (4)
- Form of Registration Rights Agreement (Filed With SEC on November 4, 2024)
- Securities Purchase Agreement, dated November (Filed With SEC on November 4, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on November 4, 2024)
- Neurogene Inc. 2023 Employee Stock Purchase Plan (Filed With SEC on December 19, 2023)
- Purchase Order, dated November 25, 2020, by and between Neoleukin Therapeutics, Inc. and Rigaku Americas Corporation (Filed With SEC on March 25, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on July 2, 2020)
- Underwriting Agreement, dated July 1, 2020 (Filed With SEC on July 2, 2020)
- Neoleukin Therapeutics, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on May 6, 2020)
- Exchange Agreement, dated December 17, 2019, by and among Neoleukin Therapeutics, Inc., 667, L.P. and Baker Brothers Life Sciences, L.P (Filed With SEC on December 19, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on December 19, 2019)
- Underwriting Agreement, dated December 17, 2019 (Filed With SEC on December 19, 2019)
- Amendment No. 1 to the Facility Use Agreement, dated April 17, 2019, by and between Institute for Systems Biology and Neoleukin Therapeutics, Inc (Filed With SEC on August 12, 2019)
- Facility Use Agreement, dated December 4, 2018, by and between Institute for Systems Biology and Neoleukin Therapeutics, Inc (Filed With SEC on August 12, 2019)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 20, 2016)
- 5,350,000 Shares Aquinox Pharmaceuticals, Inc. COMMON STOCK, PAR VALUE $0.000001 PER SHARE UNDERWRITING AGREEMENT September 19, 2016 (Filed With SEC on September 20, 2016)
- 5,500,000 Shares Aquinox Pharmaceuticals, Inc. COMMON STOCK, PAR VALUE $0.000001 PER SHARE UNDERWRITING AGREEMENT September 9, 2015 (Filed With SEC on September 10, 2015)
- ASSET PURCHASE AGREEMENT among AQUINOXPHARMACEUTICALS INC. and BIOLIPOX AB (publ.) and OREXO AB (publ.) Dated: August 19th, 2009 (Filed With SEC on February 28, 2014)
- [] Shares AQUINOX PHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on February 28, 2014)
- SECURITY AGREEMENT (Filed With SEC on January 28, 2014)
- SECURITY AGREEMENT (Filed With SEC on January 28, 2014)
- LOAN AGREEMENT (Filed With SEC on January 28, 2014)
- ASSET PURCHASE AGREEMENT among AQUINOXPHARMACEUTICALS INC. and BIOLIPOX AB (publ.) and OREXO AB (publ.) Dated: August 19th, 2009 (Filed With SEC on January 28, 2014)
- AQUINOX PHARMACEUTICALS INC. AQUINOX PHARMACEUTICALS (USA) INC. JOINT CANADIAN STOCK OPTION PLAN AS AMENDED AND RESTATED AS OF JUNE 8, 2007 (Filed With SEC on January 28, 2014)
- WARRANT TO PURCHASE STOCK (Filed With SEC on January 28, 2014)
- AMENDED & RESTATED EXCHANGE AGREEMENT (Filed With SEC on January 28, 2014)
- AMENDMENT NO. 3 TO SHAREHOLDERS AGREEMENT (Filed With SEC on January 28, 2014)
- AMENDMENT NO. 2 TO SHAREHOLDERS AGREEMENT (Filed With SEC on January 28, 2014)
- AMENDMENT TO SHAREHOLDERS AGREEMENT (Filed With SEC on January 28, 2014)
- AMENDED & RESTATED SHAREHOLDERS AGREEMENT (Filed With SEC on January 28, 2014)
- AMENDED AND RESTATED QUALIFICATION AND REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 28, 2014)
